NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 26, 2024 $0.279 -6.40% $0.327 X 85.44% 0
Jun 26, 2024 $0.286 -4.00% $0.327 X 87.63% 0
Nathan Smith Nathan Smith @NathanSmith.132703
Jun 26, 2024 Bullish $0.327 V 1
Jun 24, 2024 $0.228 -7.83% $0.262 X 86.83% 0
Jun 24, 2024 $0.235 -4.89% $0.262 X 89.60% 0
Jun 24, 2024 Bullish $0.262 V 1
May 30, 2024 $0.259 -4.69% $0.317 X 81.78% 0
May 30, 2024 $0.264 -2.93% $0.317 X 83.29% 0
JS JS Pro
May 30, 2024 $0.280 +2.94% $0.317 V 88.33% 1
taylor gatten taylor gatten @taylorgatten.131487
May 30, 2024 Bearish $0.317 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE